Current Urology Reports

, Volume 6, Issue 3, pp 177–182

What’s new in the field of prostate cancer chemoprevention?

  • Kanwaljit Mahal
  • Javier Hernandez
  • Joseph W. Basler
  • Ian M. Thompson
Article

DOI: 10.1007/s11934-005-0005-6

Cite this article as:
Mahal, K., Hernandez, J., Basler, J.W. et al. Curr Urol Rep (2005) 6: 177. doi:10.1007/s11934-005-0005-6

Abstract

Chemoprevention trials for several malignancies are completed, planned, or underway. Prostate cancer is one of the most common forms of cancer and understandably has received considerable recent attention as a potential target for chemoprevention. This article examines chemoprevention trials for prostate cancer, including the Prostate Cancer Prevention Trial, Selenium and Vitamin E Cancer Prevention Trial, and cyclooxygenase inhibitors in the prevention of prostate cancer.

Copyright information

© Current Science Inc 2005

Authors and Affiliations

  • Kanwaljit Mahal
  • Javier Hernandez
    • 1
  • Joseph W. Basler
  • Ian M. Thompson
  1. 1.Division of UrologyUniversity of Texas Health Science CenterSan AntonioUSA

Personalised recommendations